Regulatory B-cell states in NSCLC immunotherapy resistance: mechanisms, spatial context and translational implications

Xin Wang, Xi Li, Jing Zhou, Kai Yang, Rong Hu, Bin Pan · 2026

Read Regulatory B-cell states in NSCLC immunotherapy resistance: mechanisms, spatial context and translational implications by Xin Wang, Xi Li, Jing Zhou, Kai Yang, Rong Hu, Bin Pan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13578191.txt.

Description

Xin Wang and co-authors offer a 2026 review on why immune drugs lose their grip in non-small cell lung cancer. Checkpoint drugs, which free immune cells to attack tumors, help only some patients for long. Most writing on that failure centers on T cells, so the authors turn instead to regulatory B cells, a group that can calm immune attack.

The review argues these B cells are best seen as states that tumors switch on, not as one fixed cell type. Where they sit matters, notably inside small immune clusters near the tumor. The authors map how such states blunt anti-tumor defense, mix with other calming cell groups, and might guide drug plans that act on place and function.

Catalog record

CREATORXin Wang, Xi Li, Jing Zhou, Kai Yang, Rong Hu, Bin Pan
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49343
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13578191

Browse the full library · About the Tower of Babel